Real‐world retrospective study in elderly patients aged 65 years and older with type 2 diabetes mellitus treated with daily oral semaglutide ( SEMA ‐elderly)

Documenti analoghi

• Effectiveness and safety of daily oral semaglutide in people with type 2 diabetes mellitus switching from sulfonylureas: A real‐world retrospective study
  di: Silvana Costa, et al.
  Pubblicazione: (2025)
• Real‐world glycated haemoglobin changes among type 2 diabetes mellitus patients treated with a maintenance dose of 7 mg or 14 mg of oral semaglutide
  di: Caroline Swift, et al.
  Pubblicazione: (2024)
• Real‐world evaluation of clinical outcomes in Dutch patients with type 2 diabetes treated with oral semaglutide: A retrospective, observational cohort study using the PHARMO data network
  di: Abigail Postema, et al.
  Pubblicazione: (2025)
• PIONEER REAL Saudi Arabia: A multicentre, prospective, real‐world study of once‐daily oral semaglutide use in adults with type 2 diabetes in Saudi Arabia
  di: Hussein ElBadawi, et al.
  Pubblicazione: (2025)
• Efficacy and safety of oral semaglutide treatment in a Danish type 2 diabetes outpatient clinic: Real‐world evidence
  di: Alexandra A. Weinreich, et al.
  Pubblicazione: (2025)